Secondary antibody deficiency in chronic lymphocytic leukemia and non-Hodgkin lymphoma: Recommendations from an international expert panel-Reference-Cited by-同舟云学术

Secondary antibody deficiency in chronic lymphocytic leukemia and non-Hodgkin lymphoma: Recommendations from an international expert panel

Published:2023-03 Issue: Volume:58 Page:101020
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Jolles Stephen,Giralt Sergio,Kerre Tessa,Lazarus Hillard M.,Mustafa S. Shahzad,Papanicolaou Genovefa A.,Reiser Marcel,Ria Roberto,Vinh Donald C.,Wingard John R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference102 articles.

1. The expanding field of secondary antibody deficiency: causes, diagnosis, and management;Patel;Front Immunol,2019

2. Secondary immunodeficiencies, including HIV infection;Chinen;J Allergy Clin Immunol,2010

3. Secondary antibody deficiency - causes and approach to diagnosis;Srivastava;Clin Med (Lond),2016

4. Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9);Cesaro;Leukemia.,2022

5. Chapter 18 - Hypogammaglobulinemia and common variable immune deficiency;Cunningham-Rundles,2020

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment patterns and burden of infection in patients with chronic lymphocytic leukemia and secondary immunodeficiency: a retrospective database study;Annals of Hematology;2024-09-12

2. IgG testing, immunoglobulin replacement therapy, and infection outcomes in patients with CLL or NHL: real-world evidence;Blood Advances;2024-08-14

3. Non-Hodgkin lymphoma incidence, mortality, and survival trends in Brunei Darussalam from 2011 to 2020;BMC Cancer;2024-08-12

4. Burden of Infection in Patients With and Without Secondary Immunodeficiency Disease Following Diagnosis of a Mature B Cell Malignancy;Clinical Lymphoma Myeloma and Leukemia;2024-08

5. Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines;Blood Reviews;2024-05